Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025
Bristol Myers Squibb (NYSE: BMY) has scheduled its first quarter 2025 financial results announcement for Thursday, April 24, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313006466/en/
Media Relations:
media@bms.com
Investor Relations:
investor.relations@bms.com
Source: Bristol Myers Squibb